Xiaoping Chen

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents. Top assignees: Beijing Fswelcome Technology Development Co., Ltd., Beijing Showby Pharmaceutical Co., Ltd., Yingu Pharmaceutical Co., Ltd.. Active years: 2013-2025.

USPTO Granted Patents = 7

% Patents Active = 71.4

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 5(Granted Patents)

Location History:

Haidian District, CN (2013 - 2014)
Beijing, CN (2015 - 2022)

Company Filing History:

3 out of 4

Beijing Fswelcome Technology Development Co., Ltd.

patents

2 out of 3

Beijing Showby Pharmaceutical Co., Ltd.

patents

2 out of 3

Yingu Pharmaceutical Co., Ltd.

patents

Years Active: 2013-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358908 - Crystals, preparation method and application of a muscarinic receptor antagonist (2025-07-15),

2. 11447485 - Class of bifunctional compounds with quanternary ammonium salt structure (2022-09-20),

3. 9725477 - Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino (2017-08-08),

4. 9175024 - Platinum compound having amino or alkylamino-containing succinic acid derivatives as leaving group, preparation method thereof, and use thereof (2015-11-03),

5. 9138421 - Platinum compounds for treating cell proliferative diseases, preparation method and use thereof (2015-09-22),

6. 8673981 - Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof (2014-03-18),

7. 8497305 - Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof (2013-07-30),

Title: Innovations and Contributions of Inventor Xiaoping Chen

Introduction

Xiaoping Chen is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 7 patents, his work has garnered attention for its potential impact on medical treatments.

Latest Patents

Xiaoping Chen's latest patents include innovative formulations and methods related to muscarinic receptor antagonists. One of his notable inventions is the preparation method and application of a quaternary ammonium salt structure compound, specifically (2R,3R)-3-[(2-cyclopentyl-2-hydroxy-2-phenyl)ethoxy]-1-(3-phenoxypropyl) azabicyclo[2,2,2]octylonium bromide (Compound I). This invention details the characteristics of Type-A and Type-B crystals of Compound I, including their diffraction peaks in X-ray powder diffraction patterns. Additionally, he has developed a class of bifunctional compounds with quaternary ammonium salt structures that show promise in treating pulmonary disorders such as COPD and asthma.

Career Highlights

Throughout his career, Xiaoping Chen has worked with various companies, including Beijing Fswelcome Technology Development Co., Ltd. and Beijing Showby Pharmaceutical Co., Ltd. His expertise in pharmaceutical development has positioned him as a key figure in the industry.

Collaborations

Xiaoping Chen has collaborated with notable colleagues, including Shouming Wen and Yashi Yan, who have contributed to his research and development efforts.

Conclusion

Xiaoping Chen's innovative work in the pharmaceutical field demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of complex compounds and their applications in treating serious health conditions.